Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Orthopedics
Description:
Today, we're exploring osteoporosis – a condition where bones become weak and more likely to fracture. Many people don’t realise that bone loss can begin silently in your 30s and 40s, so it’s important to take steps early to protect your bone health. Simple habits like regular weight-bearing exercise, getting enough calcium and vitamin D, and avoiding smoking and excessive alcohol can make a big difference. Talk to your doctor about your personal risk factors, especially if osteoporosis runs in your family. Remember, strong bones are built over a lifetime. Start caring for them today, and you’ll thank yourself in the years to come.
See More Webinars @ Hidoc Webinars
1.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
2.
Year in Review: Multiple Myeloma
3.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
4.
Beyond What Is Visible in Myelofibrosis?
5.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
1.
Best Clinical Practices in Hematology
2.
The Growing Challenge of Haematological Malignancies in Older Adults
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
5.
Geriatric Oncology and Treatment Sequencing: Evidence-Based Approaches for the Aging Cancer Population
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge